Zynerba Pharmaceuticals Story

ZYNEDelisted Stock  USD 1.30  0.04  3.17%   
About 55% of Zynerba Pharmaceuticals' shareholders are presently thinking to get in. The analysis of current outlook of investing in Zynerba Pharmaceuticals suggests that some traders are interested regarding Zynerba Pharmaceuticals' prospects. Zynerba Pharmaceuticals' investor sentiment overview provides quick insight into current market opportunities from investing in Zynerba Pharmaceuticals. The current market sentiment, together with Zynerba Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Zynerba Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Zynerba Pharmaceuticals stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Zynerba daily returns and investor perception about the current price of Zynerba Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
  

Requested story not found. it has been either deleted or moved. View all stories for Zynerba Pharmaceuticals.

Zynerba Pharmaceuticals Latest Timeline

Zynerba Pharmaceuticals is listed for 1.30. The company has Price to Book (P/B) ratio of 0.54. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Zynerba Pharmaceuticals recorded a loss per share of 0.8. The entity had not issued any dividends in recent years.
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Consideration for investing in Zynerba Stock

If you are still planning to invest in Zynerba Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zynerba Pharmaceuticals' history and understand the potential risks before investing.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope